IP
Week in Review: August 29–September 2
Week in Review: August 29–September 2
Jef Akst | Sep 2, 2016
Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer
Do Patents Promote or Stall Innovation?
Do Patents Promote or Stall Innovation?
Catherine Offord | Jun 1, 2016
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
“Heroes of CRISPR” Disputed
“Heroes of CRISPR” Disputed
Tracy Vence | Jan 19, 2016
Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.
Opinion: Translation Nation
Opinion: Translation Nation
Kathleen Marsman and Lisa McKerracher | Nov 18, 2015
What’s in store for commercialization grants at the Canadian Institutes of Health Research?
<em>TS</em> Picks: January 29, 2014
TS Picks: January 29, 2014
Tracy Vence | Jan 29, 2015
Celebrating lab techs; Myriad settles suits; publish in top-tier journals or perish
Keeping Up with IP
Keeping Up with IP
Kate Yandell | Sep 1, 2014
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
Yet Another Lawsuit over Genetic Tests
Yet Another Lawsuit over Genetic Tests
Tracy Vence | Jun 17, 2014
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.
Week in Review: August 19–23
Week in Review: August 19–23
Tracy Vence | Aug 23, 2013
The importance of smORFs; America Invents Act and innovation in biotech; birds adjust their behavior to avoid cars; in defense of fundamental science
Opinion: AIA Does Not Discriminate
Opinion: AIA Does Not Discriminate
G. Nagesh Rao | Aug 21, 2013
The America Invents Act (AIA) was a step in the right direction for US competitiveness and open innovation.
Medicines for the World
Suerie Moon and Ellen â??t Hoen, Suerie Moon and Ellen â??t Hoen | Oct 1, 2012
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.